- Home
- MSBI vs RCKT Comparison
MSBI vs RCKT Comparison
Compare MSBI & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSBI
- RCKT
- Stock Information
- Founded
- MSBI 1881
- RCKT 1999
- Country
- MSBI United States
- RCKT United States
- Employees
- MSBI N/A
- RCKT N/A
- Industry
- MSBI Major Banks
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- MSBI Finance
- RCKT Health Care
- Exchange
- MSBI Nasdaq
- RCKT Nasdaq
- Market Cap
- MSBI 386.6M
- RCKT 328.6M
- IPO Year
- MSBI 2016
- RCKT N/A
- Fundamental
- Price
- MSBI $18.48
- RCKT $3.64
- Analyst Decision
- MSBI Hold
- RCKT Buy
- Analyst Count
- MSBI 3
- RCKT 13
- Target Price
- MSBI $20.67
- RCKT $12.96
- AVG Volume (30 Days)
- MSBI 117.7K
- RCKT 5.8M
- Earning Date
- MSBI 07-24-2025
- RCKT 08-07-2025
- Dividend Yield
- MSBI 7.18%
- RCKT N/A
- EPS Growth
- MSBI N/A
- RCKT N/A
- EPS
- MSBI 1.60
- RCKT N/A
- Revenue
- MSBI $268,067,999.00
- RCKT N/A
- Revenue This Year
- MSBI $26.04
- RCKT N/A
- Revenue Next Year
- MSBI N/A
- RCKT $591.46
- P/E Ratio
- MSBI $10.79
- RCKT N/A
- Revenue Growth
- MSBI 1.35
- RCKT N/A
- 52 Week Low
- MSBI $14.79
- RCKT $2.19
- 52 Week High
- MSBI $28.08
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- MSBI 60.85
- RCKT 62.31
- Support Level
- MSBI $17.18
- RCKT $2.88
- Resistance Level
- MSBI $17.87
- RCKT $4.10
- Average True Range (ATR)
- MSBI 0.55
- RCKT 0.26
- MACD
- MSBI 0.06
- RCKT 0.09
- Stochastic Oscillator
- MSBI 98.58
- RCKT 63.78
About MSBI Midland States Bancorp Inc.
Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.